Health Affairs

A Better Balance Between Accelerated Access And High-Priced New Drugs: A New Conditional Approval Option

There are two different storms brewing in the pharmaceutical world. On the one hand there is increasing opposition to the very high prices of drugs. On the other hand there is ever more pressure to accelerate access to drugs for seriously ill patients...

Published Mon, Mar 20 2017 8:51 AM by Health Affairs BlogHealth Affairs Blog

Filed under: Costs and Spending, Drugs and Medical Technology, drug pricing, Drugs and Medical Innovation, Duchenne Muscular Dystrophy, conditional approval, parallel track, accelerated approval, early access

Taming Health Care Spending: Could State Rate Setting Work?

For more than three and a half decades health care expenditures in the United States have grown at a much higher rate than those in other wealthy nations. Although this trend has moderated in recent years, most observers believe that expenditures, which...

Published Mon, Mar 20 2017 8:27 AM by Health Affairs BlogHealth Affairs Blog

Filed under: Health Policy Lab, Payment Policy, Insurance and Coverage, Costs and Spending, Medicare DRG program, national health expenditures, Vermont all-payer ACO System, Resource-based relative value scale, rate regulation

A Response To A Critique Of The Urban Institute Model Of Financing Long-Term Services And Supports

In a recent Health Affairs Blog post , Mark Warshawsky raises a number of objections to our simulations of financing options for long-term services and supports (LTSS), described in our recent Health Affairs article . As is true for any complex model...

Published Fri, Mar 17 2017 8:38 AM by Health Affairs BlogHealth Affairs Blog

Filed under: Aging, Long-term Services and Supports, aging population, DYNASIM

How Should We Measure The Distribution Of Health In A Population?

Population health has been defined as “the health outcomes of a group of individuals, including the distribution of such outcomes within the group.” Measuring population health and its distribution can unite groups across sectors around a set of clear...

Published Fri, Mar 17 2017 7:53 AM by Health Affairs BlogHealth Affairs Blog

Filed under: Population Health, Global Health Policy, population health metrics, population segmentation, Delphi Study, determinants of health

What’s Behind 2.5 Million New Health Jobs?

December 2007 marked the start of the most severe recession in modern times. For more than two years, the economy shed jobs. By the start of 2010, there were 8.6 million fewer jobs than at the start of the recession. These losses would have been greater...

Published Fri, Mar 17 2017 7:15 AM by Health Affairs BlogHealth Affairs Blog

Filed under: Hospitals, Costs and Spending, Health Professionals, efficiency, health sector job growth, diagnosing and treating practitioners, 2007 recession, ambulatory care settings

In This Next Phase Of Health Reform, We Cannot Overlook Long Term Care

It is becoming apparent that President Trump and the 115th Congress cannot start over with health care reform. Whether you love, begrudgingly support, or fervently hate the Affordable Care Act (ACA), a clean slate is not possible. First, ACA implementation...

Published Thu, Mar 16 2017 7:12 AM by Health Affairs BlogHealth Affairs Blog

Filed under: Medicare, Long-Term Care, Costs and Spending, Medicaid and CHIP, Long-term Services and Supports, ACA repeal and replace, family caregivers, National Family Caregiver Support Program, long term care insurance

Marketplace Enrollment Down From Last Year Following Post-Trump Inauguration Drop-Off

Editor’s note: Last month, Health Affairs launched “Eye on Health Reform, a series of articles by Tim Jost on the health reform discussion and the debate over repealing, replacing, and repairing the Affordable Care Act. These articles appear...

Published Thu, Mar 16 2017 4:28 AM by Health Affairs BlogHealth Affairs Blog

Filed under: Following the ACA, Insurance and Coverage, 21st Century Cures Act, open enrollment period, ACA Marketplaces

Health Affairs Web First: Repeated TV Ads Increased Enrollment During The ACA’s First Enrollment Period

In the fall of 2013 television viewers in many US media markets saw numerous ads about the new Affordable Care Act (ACA) Marketplaces. The ads informed consumers about the insurance products and how to enroll. A new study , released by Health Affairs...

Published Wed, Mar 15 2017 1:56 PM by Health Affairs BlogHealth Affairs Blog

Filed under: Elsewhere@ Health Affairs, Web First

A Call To The Palliative Care Community For A Patient-Centered Response To Medical Aid In Dying

During the past 20 years, the end-of-life care community has devoted its energy, resources, and time into developing the medical sub-specialty of palliative medicine and promoting integration of palliative modalities into treatment of advanced illness...

Published Wed, Mar 15 2017 8:00 AM by Health Affairs BlogHealth Affairs Blog

Filed under: Quality, End-of-Life Care, Palliative Care, hospice, End of Life & Serious Illness, medical aid in dying

Private Payer Participation In Coverage With Evidence Development: A Case Study

Driven by the escalating costs of both health care delivery and research, the concept of health care value is of increasing interest to both payers and providers. In this respect, the randomized controlled trial (RCT) often falls short. RCTs do not always...

Published Tue, Mar 14 2017 8:00 AM by Health Affairs BlogHealth Affairs Blog

Filed under: Medicare, Featured, Insurance and Coverage, Organization and Delivery, Costs and Spending, Women's Health, PCORI, coverage with evidence development, Drugs and Medical Innovation, Wisdom Study, Blue Shield of California, comparative effectiveness studies

How Do We Protect Patients From False Promises In Right-To-Try Laws?

My sister Gale had exhausted every option. Metastatic cancer raged through her body, defeating all conventional treatments. She faced a final decision: succumb to the disease, or wage one last battle with an experimental bone marrow transplant known to...

Published Tue, Mar 14 2017 7:00 AM by Health Affairs BlogHealth Affairs Blog

Filed under: Quality, right to try, Compassionate Use, End of Life & Serious Illness, experimental therapies, terminal illness

CBO Projects Coverage Losses, Cost Savings From AHCA; Administration Signals Flexibility To Governors On Waivers

Late in the afternoon on March 13, 2017, the Congressional Budget Office issued a cost estimate on the House Republican leadership’s American Health Care Act (AHCA). The headlines of the report have already been widely reported: CBO projects that, if...

Published Tue, Mar 14 2017 5:42 AM by Health Affairs BlogHealth Affairs Blog

Filed under: Following the ACA, Insurance and Coverage, Costs and Spending, Medicaid and CHIP

Request For Abstracts: Diffusion Of Innovation

Health Affairs is planning a theme issue for February 2018 that will provide a broad look at diffusion of innovations in the health care delivery system. We plan to publish about 20 peer-reviewed articles including empirical research, systematic reviews...

Published Mon, Mar 13 2017 12:17 PM by Health Affairs BlogHealth Affairs Blog

Filed under: Elsewhere@ Health Affairs, request for abstracts, Health Affairs journal

A Closer Look: House GOP Bills On Stop-Loss Coverage, Wellness Programs, And Association Health Plans

As reported earlier here , the House Education and Workforce Committee advanced three health care bills on March 8, 2017. These bills are not part of the American Health Care Act, which is moving through the House of Representatives under budget reconciliation...

Published Mon, Mar 13 2017 11:02 AM by Health Affairs BlogHealth Affairs Blog

Filed under: Following the ACA, Insurance and Coverage, Americans With Disabilities Act, Genetic Information Nondiscrimination Act, association health plans, stop-loss coverage

To Battle The Opioid Overdose Epidemic, Deploy The ‘Cascade of Care’ Model

Despite a plateau in opioid prescribing , opioid-related overdose deaths have continued to climb in epidemic proportion. Much of the recent rise is related to unpredictable adulteration of heroin and black market pills with fentanyl and other potent synthetics...

Published Mon, Mar 13 2017 7:56 AM by Health Affairs BlogHealth Affairs Blog

Filed under: Public Health, Quality, Population Health, Featured, Health Policy Lab, Costs and Spending, HIV/AIDS, 21st Century Cures Act, medication-assisted treatment, opioid epidemic, Cascade of Care, Substance Abuse and Mental Health Services Administration, State Targeted Response, quality outcome metrics

Syndication

Recent Posts

Tags

Archives